We are live on ! Find out more
SC

Schulhoff & Co Portfolio holdings

AUM $243M
1-Year Est. Return 17.47%
This Fund
S&P 500
This Quarter Est. Return
+3.51%
1 Year Est. Return
+17.47%
3 Year Est. Return
+42.69%
5 Year Est. Return
+58.83%
10 Year Est. Return
+178.36%
AUM
$238M
AUM Growth
+$3.32M
Cap. Flow
-$2.31M
Cap. Flow %
-0.97%
Top 10 Hldgs %
40.65%
Holding
138
New
3
Increased
34
Reduced
36
Closed
6

Top Buys

Rank Stock Value
1
CTMX icon
CytomX Therapeutics
CTMX
+$1.42M
2
PSLV icon
Sprott Physical Silver Trust
PSLV
+$566K
3
Q
Qnity Electronics Inc
Q
+$357K
4
CB icon
Chubb
CB
+$189K
5
WU icon
Western Union
WU
+$148K

Top Sells

Rank Stock Value
1
AVDL
Avadel Pharmaceuticals
AVDL
+$2.1M
2
PYXS icon
Pyxis Oncology
PYXS
+$611K
3
DD icon
DuPont de Nemours
DD
+$452K
4
SLV icon
iShares Silver Trust
SLV
+$441K
5
CTAS icon
Cintas
CTAS
+$290K

Sector Composition

Rank Sector Weight
1 Financials 21.72%
2 Consumer Staples 17.43%
3 Industrials 12.82%
4 Healthcare 12.68%
5 Technology 9.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TJX icon
51
TJX Companies
TJX
$171B
$1.08M 0.45%
7,012
+34
+0.5% +$5.03K
GEV icon
52
GE Vernova
GEV
$278B
$1.07M 0.45%
1,631
– –
NSC icon
53
Norfolk Southern
NSC
$75.9B
$1.05M 0.44%
3,635
– –
EL icon
54
Estee Lauder
EL
$30B
$1.03M 0.43%
9,816
-192
-2% -$18.6K
NEM icon
55
Newmont
NEM
$97B
$984K 0.41%
9,850
-600
-6% -$54.2K
BF.B icon
56
Brown-Forman Class B
BF.B
$11.9B
$925K 0.39%
35,493
-894
-2% -$25.2K
SYY icon
57
Sysco
SYY
$39.3B
$913K 0.38%
12,390
+10
+0.1% +$761
HUBB icon
58
Hubbell
HUBB
$25.5B
$883K 0.37%
1,988
– –
SHEL icon
59
Shell
SHEL
$236B
$854K 0.36%
11,622
+10
+0.1% +$737
BF.A icon
60
Brown-Forman Class A
BF.A
$12.1B
$848K 0.36%
32,250
– –
ED icon
61
Consolidated Edison
ED
$41.4B
$836K 0.35%
8,416
– –
NVS icon
62
Novartis
NVS
$291B
$834K 0.35%
6,050
-7
-0.1% -$917
RYN icon
63
Rayonier
RYN
$6.66B
$817K 0.34%
37,717
-107
-0.3% -$2.42K
NEE icon
64
NextEra Energy
NEE
$186B
$791K 0.33%
9,857
+64
+0.7% +$5.3K
HSY icon
65
Hershey
HSY
$35.4B
$761K 0.32%
4,181
– –
INTC icon
66
Intel
INTC
$487B
$754K 0.32%
20,445
– –
ET icon
67
Energy Transfer Partners
ET
$69.5B
$736K 0.31%
44,625
+6,305
+16% +$105K
LHX icon
68
L3Harris
LHX
$53B
$728K 0.31%
2,480
– –
CAT icon
69
Caterpillar
CAT
$404B
$683K 0.29%
1,193
-28
-2% -$15.6K
PM icon
70
Philip Morris
PM
$296B
$680K 0.29%
4,238
+2
+0% +$310
SPG icon
71
Simon Property Group
SPG
$74.1B
$654K 0.28%
3,531
– –
DIS icon
72
Walt Disney
DIS
$173B
$636K 0.27%
5,594
– –
OGE icon
73
OGE Energy
OGE
$10.2B
$633K 0.27%
14,825
– –
SPRY icon
74
ARS Pharmaceuticals
SPRY
$741M
$596K 0.25%
51,150
+7,650
+18% +$74.4K
WFC icon
75
Wells Fargo
WFC
$267B
$588K 0.25%
6,309
+2
+0% +$174
1 2
3
4 5

Similar funds

HCM
Hutner Capital Management Manchester, Vermont $243M AUM 10.01% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
SC
Solstein Capital Menlo Park, California $244M AUM 29.05% 1-Year Est. Return
YP
YANKCOM Partnership Yankton, South Dakota $243M AUM 21.59% 1-Year Est. Return
HBS
Howard Bailey Securities Fort Wayne, Indiana $243M AUM 13.36% 1-Year Est. Return
QHA
Quarry Hill Advisors St Paul, Minnesota $243M AUM 24.02% 1-Year Est. Return
GIM
GE Investment Management Norwalk, Connecticut $244M AUM 41.62% 1-Year Est. Return
BB
Burford Brothers Dallas, Texas $244M AUM 24.94% 1-Year Est. Return

Schulhoff & Co's Q4 2025 Portfolio in Review

As of Q4 2025, Schulhoff & Co held 138 positions worth $238M, up 1.4% from $234M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Schulhoff & Co's Q4 2025 filing shows 3 new, 34 increased, 36 reduced and 6 closed positions. Its largest new stake was CytomX Therapeutics: 374,850 shares worth $1.6M. The largest sale was Avadel Pharmaceuticals, an estimated $2.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, up from 21% a quarter earlier, followed by Consumer Staples and Industrials.

  • Schulhoff & Co's largest Q4 2025 buy was CytomX Therapeutics: 374,850 shares worth $1.6M.
  • Schulhoff & Co added most to Sprott Physical Silver Trust in Q4 2025, an estimated $566K increase.
  • Schulhoff & Co's biggest Q4 2025 reduction was DuPont de Nemours, cutting an estimated $452K.
  • Schulhoff & Co fully exited Avadel Pharmaceuticals in Q4 2025, selling an estimated $2.1M.
  • Schulhoff & Co's ten largest holdings make up 41% of its $238M portfolio in Q4 2025.
  • Schulhoff & Co opened 3 new positions and closed 6 in Q4 2025.
  • Schulhoff & Co's portfolio value rose 1.4% quarter-over-quarter to $238M.

Based on Schulhoff & Co's 13F filing for Q4 2025, filed 11 Feb 2026.